BGLC_OUT_1 [2025-04-03 12:45:57 -0400] 3515 Bytes | 942 tokens | Cum: 942 tkns (11.77% of 8k)
==========================================================================

Booyah, my friends! It's already 12:45:56 PM on Thu Apr 03, 2025 -0400, and I've got my eyes locked on BioNexus Gene Lab (BGLC), pushing up to 0.299159 from 0.2531. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

--- COMPANY PROFILE ---
Company: BioNexus Gene Lab (BGLC)
IPO: 2020-03-11 (5 Years Ago)
Market Cap: $4,671,592
Shares Outstanding: 17,970,000
Industry: SERVICES-MEDICAL LABORATORIES
Exchange: XNAS
Description: BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Here's the first list of news for BioNexus Gene Lab:

C1 - Mar-08-25 11:10AM - Bionexus Gene Lab enters partnership with ML Tech
C2 - Mar-07-25 11:00AM - BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy
C3 - Mar-05-25 11:00AM - BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
C4 - Sep-25-24 11:31AM - BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
C5 - Sep-13-24 12:05PM - BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
C6 - Sep-12-24 01:23PM - BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
C7 - Sep-11-24 11:05AM - BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
C8 - Aug-27-24 11:35AM - BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

Prior AI Reports for BGLC:
1. 2025-04-01 – Score: 45 – Target: 0.3600 – Highs: 0.2863 / 0.2700 / –
challenging-profitability-amid-high-insider-confidence-potential-ahead
2. 2025-03-26 – Score: 46 – Target: 0.4960 – Highs: 0.3200 / 0.3200 / 0.26
high-insider-ownership-amid-slowing-sales-growth-raises-questions

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on BioNexus Gene Lab (BGLC)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

BGLC_OUT_3 [2025-04-03 12:46:02 -0400] 1104 Bytes | 261 tokens | Cum: 1205 tkns (15.06% of 8k)
==========================================================================

Showing C1 (chunk 1 of 2): C1:
**Bionexus Gene Lab enters partnership with ML Tech**
Date: Mar-08-25 11:10AM
Source: (TipRanks)
URL: https://finance.yahoo.com/news/bionexus-gene-lab-enters-partnership-161052246.html

BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth strategies. Through this partnership, BGLC plans to leverage ML Tech’s digital asset trading infrastructure to grow itsEthereumholdings. ML Tech, known for its institutional-grade trading strategies and advanced quantitative models, will provide BioNexus with tailored investment solutions designed to maximize returns while maintaining stringent risk management protocols.

Discover stocks' market position with detailedcompetitor analyses.

Published first onTheFly– the ultimate source for real-time, market-moving breaking financial news.Try Now>>

Questions or Comments about the article?

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_OUT_5 [2025-04-03 12:46:02 -0400] 1039 Bytes | 307 tokens | Cum: 1580 tkns (19.75% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T21:05:41Z - 12 Industrials Stocks Moving In Monday's After-Market Session - BioNexus Gene Lab (NASDAQ:BGLC), Elo...
A2 - 2025-03-28T12:05:42Z - 12 Industrials Stocks Moving In Friday's Pre-Market Session - Argan (NYSE:AGX), BioNexus Gene Lab (N...
A3 - 2025-03-27T21:05:43Z - 12 Industrials Stocks Moving In Thursday's After-Market Session - Argan (NYSE:AGX), BioNexus Gene La...
A4 - 2025-03-27T09:56:50Z - Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premar...
A5 - 2025-03-26T21:05:39Z - 12 Industrials Stocks Moving In Wednesday's After-Market Session - American Rebel Holdings (NASDAQ:A...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

BGLC_OUT_7 [2025-04-03 12:46:03 -0400] 1098 Bytes | 349 tokens | Cum: 1931 tkns (24.14% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**12 Industrials Stocks Moving In Monday's After-Market Session - BioNexus Gene Lab (NASDAQ:BGLC), Elong Power Holding (NASDAQ:ELPW)**Date: 2025-03-31Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44573146/12-industrials-stocks-moving-in-mondays-after-market-sessionGainers Microvast Holdings MVST shares rose 27.4% to $1.49 during Monday's after-market session. The company's market cap stands at $482.6 million. As per the press release, Q4 earnings came out today. Expion360 XPON stock moved upwards by 6.4% to $0.96. The company's market cap stands at $3.0 million. The company's, Q4 earnings came out today. VCI Global VCIG shares increased by 5.17% to $0.44. The company's market cap stands at $20.7 million. BioNexus Gene Lab BGLC stock rose 5.12% to $0.25. The company's market cap stands at $4.4 million. Westw

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_OUT_9 [2025-04-03 12:46:04 -0400] 1163 Bytes | 363 tokens | Cum: 2296 tkns (28.70% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-04-19T21:36:00Z - BioNexus Gene Lab Corp. Bersetuju untuk Melabur RM 1.2 juta dalam Ascension Innovation (AISB) untuk Memajukan Inovasi Kesihatan Digital menerusi penerimaan AI dalam Penjagaan Kesihatan
B2 - 2024-04-18T18:52:00Z - BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
B3 - 2024-02-14T18:18:52Z - Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B4 - 2024-02-14T13:12:33Z - Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
B5 - 2024-02-13T18:13:36Z - Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B6 - 2024-02-13T14:43:29Z - Dow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In January

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

BGLC_OUT_11 [2025-04-03 12:46:09 -0400] 1100 Bytes | 293 tokens | Cum: 2591 tkns (32.39% of 8k)
==========================================================================

Showing B4 (chunk 1 of 2): B4:
**Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/02/37123311/why-robinhood-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarketShares of Robinhood Markets, Inc. (NASDAQ: HOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.
Robinhood reported fourth-quarter revenue of $471 million, which was up 24% year-over-year. The revenue beat a Street consensus estimate of $456.8 million, according to data from Benzinga Pro. Robinhood reported earnings per share of 3 cents, which beat a Street consensus estimate of a loss of 1 cent per share.
Robinhood shares jumped 13.8% to $13.47 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers

B

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_OUT_13 [2025-04-03 12:46:10 -0400] 1151 Bytes | 269 tokens | Cum: 2954 tkns (36.93% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-07 8-K Item 7.01 Regulation FD Disclosure

On March 7, 2025, the Company issued a press release announcing a strategic partnership with ML Tech to optimize its Ethereum-based growth strategies. ML Tech, an AI-driven wealth management platform for digital assets regulated by the Nationa...

S2 - 2025-03-07 8-K Item 7.01 Regulation FD Disclosure

On March 7, 2025, the Company issued a press release announcing a strategic partnership with ML Tech to optimize its Ethereum-based growth strategies. ML Tech, an AI-driven wealth management platform for digital assets regulated by the Nationa...

S3 - 2025-03-07 8-K Item 7.01 Regulation FD Disclosure

On March 7, 2025, the Company issued a press release announcing a strategic partnership with ML Tech to optimize its Ethereum-based growth strategies. ML Tech, an AI-driven wealth management platform for digital assets regulated by the Nationa...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

BGLC_OUT_15 [2025-04-03 12:46:11 -0400] 1098 Bytes | 263 tokens | Cum: 3219 tkns (40.24% of 8k)
==========================================================================

Showing S1 (chunk 1 of 2): S1:
Item 7.01 Regulation FD Disclosure

On March 7, 2025, the Company issued a press release announcing a strategic partnership with ML Tech to optimize its Ethereum-based growth strategies. ML Tech, an AI-driven wealth management platform for digital assets regulated by the National Futures Association (NFA) and headquartered in Miami, Florida, will provide institutional-grade trading strategies to BGLC.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or th

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_OUT_17 [2025-04-03 12:46:20 -0400] 4199 Bytes | 1193 tokens | Cum: 4414 tkns (55.17% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+----------------------+------------------------+------------------------+
| Volume: 429,384 | Perf Month: -9.25% | Option/Short: No / Yes | Sales Y/Y TTM: -10.42% |
+---------------------+----------------------+------------------------+------------------------+
| Avg Volume: 834.58K | Perf Quarter: 10.83% | Short Float: 2.12% | ROE: -9.87% |
+---------------------+----------------------+------------------------+------------------------+
| Rel Volume: 1.05 | Index: - | Short Ratio: 0.28 | ROI: -9.84% |
+---------------------+----------------------+------------------------+------------------------+
| RSI (14): 50.36 | Market Cap: 5.57M | Short Interest: 0.23M | Sales Surprise: - |
+---------------------+----------------------+------------------------+------------------------+
| ATR (14): 0.04 | Shs Outstand: 17.97M | Beta: 1.76 | EPS Surprise: - |
+---------------------+----------------------+------------------------+------------------------+
| SMA20: 0.47% | Shs Float: 11.03M | Sales Q/Q: 3.00% | P/E: - |
+---------------------+----------------------+------------------------+------------------------+
| SMA50: -9.93% | Inst Own: 0.99% | Sales past 5Y: - | Earnings: - |
+---------------------+----------------------+------------------------+------------------------+
| SMA200: -18.46% | Insider Own: 38.60% | Employees: - | |
+---------------------+----------------------+------------------------+------------------------+
| Perf Week: 3.61% | Insider Trans: 0.00% | Debt/Eq: 0.02 | |
+---------------------+----------------------+------------------------+------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 2630376.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -1345370.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.297501
Average Volume: 1330964.57
30-Day High: 0.369
30-Day Low: 0.2364

[Detailed Financials: Q3 2024]
- Total Assets: $10,995,055.0
- Total Liabilities: $1,606,882.0
- Total Equity: $9,388,173.0
- Current Assets: $7,039,453.0
- Current Liabilities: $1,414,869.0

[Income Statement: Q3 2024]
- Revenue: $2,630,376.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-1,276,814.0

[Detailed Financials: Q2 2024]
- Total Assets: $11,139,727.0
- Total Liabilities: $1,593,973.0
- Total Equity: $9,545,754.0
- Current Assets: $7,842,869.0
- Current Liabilities: $1,399,358.0

[Income Statement: Q2 2024]
- Revenue: $1,974,564.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-418,148
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

BGLC_OUT_19 [2025-04-03 12:46:22 -0400] 676 Bytes | 167 tokens | Cum: 4778 tkns (59.72% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

BGLC_IN_21 [2025-04-03 12:46:22 -0400] 126 Bytes | 29 tokens | Cum: 4835 tkns (60.44% of 8k)
==========================================================================

====================================
[2025-04-03 12:46:22] # Analysis Completed
Elapsed Time: 26.02 seconds